miércoles, 24 de junio de 2026

Ophthalmology venture grabs investors’ attention, raises $330 million Ollin Biosciences is developing treatments for eye diseases

https://www.statnews.com/2026/06/24/ophthalmology-biotech-ollin-biosciences/ By Allison DeAngelisJune 24, 2026 Biotech Startups and Venture Capital Reporter

No hay comentarios: